Stockreport

OKYO Pharma Announces Distinguished Ophthalmologists with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Join its Scientific Advisory Board [Yahoo! Finance]

OKYO Pharma Limited - American Depositary Shares  (OKYO) 
PDF innovative therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and for neuropathic corneal pain (NCP), a severe ocular cond [Read more]